In December 2019, a novel and ongoing outbreak of pneumonia was reported in Wuhan city, Hubei province, China,1–4 which has caused significant concerns internationally. Chinese scientists completed isolation of this novel betacoronavirus from patients in Wuhan, and it has been subsequently named coronavirus disease 2019 (COVID-19). As of March 6, 2020, a total of 80,813 laboratory-confirmed COVID-19 infections were reported in China, leading to the deaths of 3,073 patients within the country. In Wuhan alone, 49,871 COVID-19 infections have been confirmed with 2,349 deaths and 28,511 patient recoveries.5 Designated hospitals which can manage COVID-19 effectively are limited in terms of bed availability, staffing, and resources. Nearly 70% of COVID-19 patients display no symptoms or only mild symptoms. Because there are more than 9 million citizens in Wuhan, the designated hospitals cannot admit all patients suspected...
Establishing and Managing a Temporary Coronavirus Disease 2019 Specialty Hospital in Wuhan, China
W.Z. and Y.W. contributed equally to this article.
Submitted for publication March 7, 2020. Accepted for publication March 9, 2020. Published online first on March 18, 2020.
- Views Icon Views
- Share Icon Share
- Search Site
Weihong Zhu, Yang Wang, Kui Xiao, Huilin Zhang, Yi Tian, Sean P. Clifford, Junmei Xu, Jiapeng Huang; Establishing and Managing a Temporary Coronavirus Disease 2019 Specialty Hospital in Wuhan, China. Anesthesiology 2020; 132:1339–1345 doi: https://doi.org/10.1097/ALN.0000000000003299
Download citation file: